SCHEMBL30125151

SCHEMBL30125151

Nc1nc(N)c2c(-c3ccc(F)cc3)cccc2n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 10/20 0.58
DCPS Q96C86 6/20 0.51
DAPK3 O43293 1/20 0.51
PRKD3 O94806 1/20 0.51
MAP4K4 O95819 1/20 0.51
PAK4 O96013 1/20 0.51
ABL1 P00519 1/20 0.51
NTRK1 P04629 1/20 0.51
LCK P06239 1/20 0.51
CSF1R P07333 1/20 0.51
RET P07949 1/20 0.51
IGF1R P08069 1/20 0.51
MET P08581 1/20 0.51
PDGFRB P09619 1/20 0.51
FGFR1 P11362 1/20 0.51
PRKACA P17612 1/20 0.51
FLT1 P17948 1/20 0.51
LTK P29376 1/20 0.51
GRK5 P34947 1/20 0.51
KDR P35968 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30482718 0.86 DHFR (0.56) DHFRDCPSADORA2AKCNH2
SCHEMBL12648993 0.85 DHFR (0.55) DHFRDCPSADORA2AKCNH2
SCHEMBL30482740 0.84 ADORA2A (0.55) DHFRDCPSMAP4K4ADORA2AKCNH2
SCHEMBL30482707 0.84 DHFR (0.58) DHFRDCPSMAP4K4KCNH2
SCHEMBL30482752 0.84 DHFR (0.58) DHFRDCPSADORA2AKCNH2
SCHEMBL30482758 0.84 DHFR (0.58) DHFRDCPSLCKCSF1RFGFR1
SCHEMBL21497083 0.84 DCPS (0.47) DHFRDCPSKCNH2
SCHEMBL30482755 0.83 DHFR (0.61) DHFRDCPSKDRKCNH2
SCHEMBL30482722 0.83 DHFR (0.45) DHFRDCPSKCNH2
SCHEMBL30482725 0.81 DHFR (0.46) DHFRDCPSADORA2AKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116354938-B Preparation method and application of quinazoline derivatives and analogues thereof 沈阳药科大学 2024-02-20 CN disclosed
CN-116354938-A Preparation method and application of quinazoline derivatives and analogues thereof 沈阳药科大学 2023-06-30 CN disclosed
EP-4100395-A1 QUINAZOLINE COMPOUNDS AND THE USE THEREOF IN THE TREATMENT OF CANCER Trobio Therapeutics Pty Ltd (AU) 2022-12-14 EP disclosed